Us Renal Care Laredo Dialysis is a medicare approved dialysis facility center in Laredo, Texas and it has 25 dialysis stations. It is located in Webb county at 6801 Mcpherson Road, Laredo, TX, 78041. You can reach out to the office of Us Renal Care Laredo Dialysis at (956) 725-1202. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Us Renal Care Laredo Dialysis has the following ownership type - Profit. It was first certified by medicare in February, 2001. The medicare id for this facility is 452823 and it accepts patients under medicare ESRD program.
| Name | Us Renal Care Laredo Dialysis |
|---|---|
| Location | 6801 Mcpherson Road, Laredo, Texas |
| No. of Dialysis Stations | 25 |
| Medicare ID | 452823 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 6801 Mcpherson Road, Laredo, Texas, 78041 | |
| (956) 725-1202 | |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
| NPI Number | 1891772315 |
| Organization Name | Us Renal Care Laredo Dialysis |
| Doing Business As | Usrc Laredo Lp |
| Address | 6801 Mcpherson Rd Ste 107 Laredo, Texas, 78041 |
| Phone Number | (956) 725-1202 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 68% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 12% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 20% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 53% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 24% | 14% |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 58% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 18% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 24% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 50% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 23% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 27% | 12% |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 75% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 25% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 59% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 19% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 22% | 12% |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 73 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 1 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 117 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1115 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Us Renal Care Laredo Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 119 |
| Hypercalcemia patient months | 1123 |
| Patients with Serumphosphor | 126 |
| Patients with Serumphosphor less than 3.5 mg/dL | 11 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 31 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
| Patients with Serumphosphor greater than 7 mg/dL | 9 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 99 |
| Patient months included in arterial venous fistula and catheter summaries | 911 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 50 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 15 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 118 |
| Hospitalization Rate in facility | 149.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 251.6 |
| Hospitalization Rate: Lower Confidence Limit | 95.9 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Us Renal Care Laredo Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 20.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 29.2 |
| Readmission Rate: Lower Confidence Limit | 14.1 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Us Renal Care Laredo Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .24 (Better than Expected) |
| SIR: Upper Confidence Limit | .8 |
| SIR: Lower Confidence Limit | .04 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Us Renal Care Laredo Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 109 |
| Transfusion Rate in facility | 41.4 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 79 |
| Transfusion Rate: Lower Confidence Limit | 23.5 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Us Renal Care Laredo Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 519 |
| Mortality Rate in facility | 18.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 23.9 |
| Mortality Rate: Lower Confidence Limit | 14.4 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago
Satellite Healthcare North Laredo Location: 5501 Springfield Avenue, Laredo, Texas, 78041 Phone: (956) 724-8276 |
Satellite Healthcare South Laredo Location: 910 Guadalupe St Suite B, Laredo, Texas, 78040 Phone: (956) 729-7411 |
Us Renal Care Laredo Dialysis Location: 6801 Mcpherson Road, Laredo, Texas, 78041 Phone: (956) 725-1202 |
Satellite Healthcare Southeast Laredo Location: 4151 Jaime Zapata Memorial Hwy, Laredo, Texas, 78046 Phone: (956) 791-8100 |
Us Renal Care Laredo South Dialysis Location: 4602 Bencha Road, Laredo, Texas, 78041 Phone: (956) 753-2121 |
News Archive
Suneva Medical, a privately-held aesthetic medical device company, today announced the publication of an open-label, single center, pilot study on Artefill for the treatment of atrophic acne scars conducted by James M. Spencer, M.D. M.S. and sponsored by Suneva Medical.
A new low-dose coronary computed tomography angiography (CTA) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with coronary CTA by 27 percent, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org). Coronary CTA is a common heart imaging test that helps determine if fatty or calcium deposits have narrowed a patient's coronary arteries.
WTN Services(R) and the Winetasting Network(R) a division of 1-800-Flowers.com(R) have announced they have deepened the commitment to their existing plan of industry partnerships and projects that better the community.
Oxford Gene Technology (OGT), The Molecular Genetics Company, has developed a new range of non-human fluorescence in situ hybridisation (FISH) probes, for pig, chicken and mouse. The probes were developed as part of an Innovate UK knowledge transfer partnership (KTP) funded project in collaboration with the University of Kent, and was given an ‘outstanding' award reserved for the top 10% of KTP projects.
Pfizer Oncology announced today that it will initiate a global, Phase 3 clinical trial of its investigational oral c-Met and ALK inhibitor, PF-02341066, versus standard of care chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) carrying the ALK (anaplastic lymphoma kinases) fusion gene, who have progressed on one prior treatment with a platinum-based chemotherapy.
› Verified 5 days ago